Ventures with Evidence Signal Greater than 40
In the current funding drought in Digital Health, investors are focusing their funds more on ventures that can provide
evidence of their solution’s effectiveness. Galen Growth considers peer-reviewed publications, clinical trials, and
regulatory approvals in the Evidence Signal (ES). For a complete analysis, download your own copy of Clinical Strength in Digital Health report.
Last Updated: August 21, 2023